Page last updated: 2024-08-24

telmisartan and Angina Pectoris

telmisartan has been researched along with Angina Pectoris in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akaike, M; Bando, S; Hirata, Y; Iwase, T; Koshiba, K; Kusunose, K; Niki, T; Sata, M; Soeki, T; Taketani, Y; Tomita, N; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K	1

Other Studies

1 other study(ies) available for telmisartan and Angina Pectoris

Article	Year
Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability. Journal of cardiology, 2011, Volume: 58, Issue:2 Topics: Aged; Angina Pectoris; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Sinus; Disease Progression; Drug Monitoring; Female; Humans; Inflammation Mediators; Male; Middle Aged; Plaque, Atherosclerotic; Serum Amyloid P-Component; Severity of Illness Index; Telmisartan; Tomography, Spiral Computed	2011

Article

Year

Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.

Journal of cardiology, 2011, Volume: 58, Issue:2

Topics: Aged; Angina Pectoris; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Sinus; Disease Progression; Drug Monitoring; Female; Humans; Inflammation Mediators; Male; Middle Aged; Plaque, Atherosclerotic; Serum Amyloid P-Component; Severity of Illness Index; Telmisartan; Tomography, Spiral Computed

2011